Literature DB >> 26327372

Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1.

Jooyoung Park1, Ann M Guggisberg2, Audrey R Odom1, Niraj H Tolia1.   

Abstract

Haloacid dehalogenases (HADs) are a large enzyme superfamily of more than 500,000 members with roles in numerous metabolic pathways. Plasmodium falciparum HAD1 (PfHAD1) is a sugar phosphatase that regulates the methylerythritol phosphate (MEP) pathway for isoprenoid synthesis in malaria parasites. However, the structural determinants for diverse substrate recognition by HADs are unknown. Here, crystal structures were determined of PfHAD1 in complex with three sugar phosphates selected from a panel of diverse substrates that it utilizes. Cap-open and cap-closed conformations are observed, with cap closure facilitating substrate binding and ordering. These structural changes define the role of cap movement within the major subcategory of C2 HAD enzymes. The structures of an HAD bound to multiple substrates identifies binding and specificity-determining residues that define the structural basis for substrate recognition and catalysis within the HAD superfamily. While the substrate-binding region of the cap domain is flexible in the open conformations, this region becomes ordered and makes direct interactions with the substrate in the closed conformations. These studies further inform the structural and biochemical basis for catalysis within a large superfamily of HAD enzymes with diverse functions.

Entities:  

Keywords:  C2 cap; HAD superfamily; haloacid dehalogenase; substrate specificity; sugar phosphatase

Mesh:

Substances:

Year:  2015        PMID: 26327372      PMCID: PMC4556313          DOI: 10.1107/S1399004715012067

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  40 in total

1.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 2.  Markers of fitness in a successful enzyme superfamily.

Authors:  Karen N Allen; Debra Dunaway-Mariano
Journal:  Curr Opin Struct Biol       Date:  2009-11-02       Impact factor: 6.809

3.  A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.

Authors:  Baichen Zhang; Kristin M Watts; Dana Hodge; Lisa M Kemp; David A Hunstad; Leslie M Hicks; Audrey R Odom
Journal:  Biochemistry       Date:  2011-04-11       Impact factor: 3.162

4.  Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene.

Authors:  Audrey R Odom; Wesley C Van Voorhis
Journal:  Mol Biochem Parasitol       Date:  2009-12-16       Impact factor: 1.759

5.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

6.  Analysis of the structural determinants underlying discrimination between substrate and solvent in beta-phosphoglucomutase catalysis.

Authors:  Jianying Dai; Lorenzo Finci; Chunchun Zhang; Sushmita Lahiri; Guofeng Zhang; Ezra Peisach; Karen N Allen; Debra Dunaway-Mariano
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

7.  The tail of KdsC: conformational changes control the activity of a haloacid dehalogenase superfamily phosphatase.

Authors:  Tapan Biswas; Li Yi; Parag Aggarwal; Jing Wu; John R Rubin; Jeanne A Stuckey; Ronald W Woodard; Oleg V Tsodikov
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

8.  Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.

Authors:  Sethu C Nair; Carrie F Brooks; Christopher D Goodman; Angelika Sturm; Angelika Strurm; Geoffrey I McFadden; Sandeep Sundriyal; Justin L Anglin; Yongcheng Song; Silvia N J Moreno; Boris Striepen
Journal:  J Exp Med       Date:  2011-06-20       Impact factor: 14.307

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  2 in total

1.  Engineering substrate specificity of HAD phosphatases and multienzyme systems development for the thermodynamic-driven manufacturing sugars.

Authors:  Chaoyu Tian; Jiangang Yang; Cui Liu; Peng Chen; Tong Zhang; Yan Men; Hongwu Ma; Yuanxia Sun; Yanhe Ma
Journal:  Nat Commun       Date:  2022-06-23       Impact factor: 17.694

2.  Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites.

Authors:  Ann M Guggisberg; Philip M Frasse; Andrew J Jezewski; Natasha M Kafai; Aakash Y Gandhi; Samuel J Erlinger; Audrey R Odom John
Journal:  mBio       Date:  2018-11-13       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.